Newly diagnosed hepatocellular carcinoma in patients with advanced hepatitis C treated with DAAs: A prospective population studyAntonietta Romano, A. Albertí, Paolo Angeli et al.|Journal of Hepatology|2018Cited by 166
A randomized trial of consensus interferon in combination with ribavirin as initial treatment for chronic hepatitis CGiovanna Fattovich, A. Tagger, I. Zagni et al.|Journal of Hepatology|2003Cited by 27
THU-131-Effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir for retreatment of chronic hepatitis C patients with a previous failure to direct-acting antivirals: A real-life study from the NAVIGATORE Lombardia and Veneto NetworksElisabetta Degasperi, S. Fagiuoli, Paolo Bonfanti et al.|Journal of Hepatology|2019Cited by 3
Effectiveness and safety of Sofosbuvir/Velpatasvir/Voxilaprevir for retreatment of chronic hepatitis C patients with a previous failure to direct-acting antivirals: a real-life study from the Navigatore Lombardia and Veneto NetworksElisabetta Degasperi, S. Fagiuoli, Angiola Spinetti et al.|Digestive and Liver Disease|2019Cited by 1
Impact if HBV infection in HCV/HBV coinfected patients treated with DAAs in north ItalyPaolo Fabris, Veronica Del Punta, Franco Noventa et al.|Journal of Hepatology|2020Cited by 0